Briacell TherapeuticsBCTX
13F holders, Q4 2025 (December 31)13holders
3new positions
3sold out
$7.13avg. 13F price*
At the end of Q4 2025, 13 institutions reported holding Briacell Therapeutics Corp. (BCTX) in their 13F filings, unchanged from Q3 2025. 3 opened new positions and 3 sold out. The largest holders were Flagship Harbor Advisors, LLC ($28K), Morgan Stanley ($25K) and Federation des caisses Desjardins du Quebec ($9K).
- Company
- Briacell Therapeutics Corp.
- CUSIP
- 107930307
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q4 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 3 | $29K |
| Exits | 3 | $123K |
All 13F filers, Q3 2025 → Q4 2025: 8,400 shares bought and 11,141 shares sold, net −2,741 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 13 holders
| Flagship Harbor Advisors, LLC | 0.00% | New | 4,000 | $28K |
| Morgan Stanley | 0.00% | Add +2971.1% | 3,501 | $25K |
| Federation des caisses Desjardins du Quebec | 0.00% | Add +33.1% | 1,205 | $9K |
| UBS Group AG | 0.00% | Add +896.9% | 638 | $5K |
| Royal Bank of Canada | 0.00% | No change | 100 | $1K |
| Allworth Financial LP | 0.00% | Add +1328.6% | 100 | $711 |
| Group One Trading LLC | 0.00% | No change | 70 | $498 |
| Ssa Swiss Advisors AG | 0.00% | New | 37 | $264 |
| TD Waterhouse Canada Inc. | 0.00% | No change | 19 | $135 |
| Tower Research Capital LLC (TRC) | 0.00% | New | 9 | $64 |
| HHM Wealth Advisors, LLC | 0.00% | No change | 6 | $43 |
| Wells Fargo & Company | 0.00% | No change | 1 | $7 |
| FNY Investment Advisers, LLC | 0.00% | No change | 10 | $0 |
"% of holder's portfolio" is BCTX's weight in each manager's 13F, not the share of Briacell Therapeutics Corp. the manager owns.